1. Home
  2. MDAI vs FGF Comparison

MDAI vs FGF Comparison

Compare MDAI & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • FGF
  • Stock Information
  • Founded
  • MDAI 2013
  • FGF 2012
  • Country
  • MDAI United States
  • FGF United States
  • Employees
  • MDAI N/A
  • FGF N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • FGF Property-Casualty Insurers
  • Sector
  • MDAI Health Care
  • FGF Finance
  • Exchange
  • MDAI Nasdaq
  • FGF Nasdaq
  • Market Cap
  • MDAI 27.8M
  • FGF N/A
  • IPO Year
  • MDAI N/A
  • FGF N/A
  • Fundamental
  • Price
  • MDAI $1.29
  • FGF $17.52
  • Analyst Decision
  • MDAI Strong Buy
  • FGF
  • Analyst Count
  • MDAI 2
  • FGF 0
  • Target Price
  • MDAI $4.75
  • FGF N/A
  • AVG Volume (30 Days)
  • MDAI 426.7K
  • FGF 9.6K
  • Earning Date
  • MDAI 05-06-2025
  • FGF 05-19-2025
  • Dividend Yield
  • MDAI N/A
  • FGF N/A
  • EPS Growth
  • MDAI N/A
  • FGF N/A
  • EPS
  • MDAI N/A
  • FGF N/A
  • Revenue
  • MDAI $29,581,000.00
  • FGF $17,348,000.00
  • Revenue This Year
  • MDAI N/A
  • FGF N/A
  • Revenue Next Year
  • MDAI $49.47
  • FGF N/A
  • P/E Ratio
  • MDAI N/A
  • FGF N/A
  • Revenue Growth
  • MDAI 63.83
  • FGF N/A
  • 52 Week Low
  • MDAI $0.82
  • FGF $14.21
  • 52 Week High
  • MDAI $3.25
  • FGF $38.40
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 39.65
  • FGF 38.17
  • Support Level
  • MDAI $1.04
  • FGF $16.90
  • Resistance Level
  • MDAI $1.76
  • FGF $19.25
  • Average True Range (ATR)
  • MDAI 0.16
  • FGF 0.67
  • MACD
  • MDAI -0.02
  • FGF 0.01
  • Stochastic Oscillator
  • MDAI 31.65
  • FGF 21.83

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: